Skip to main content
. 2016 Nov 11;11(1):7–14. doi: 10.22074/ijfs.2016.5145

Table 2.

Superovulation variables, serum hCG, oocytes and embryo parameters, CPRs and LBRs in relation to BMI categories and u-hCG dosages


Variable BMI
<25 (n=136) ≥25 - <30 (n=84) ≥30 (n=75) P value

Dose of HCG administered 10547.9 ± 3169.0 10333.3 ± 2784.4 10166.7 ± 2849.2 0.623
Serum hCG (IU) 12-14 hours after hCG trigger 312.7 ± 16.5a 230.4 ± 12.0b 162.8 ± 9.6c 0.001
Gn stimulation (days) 10.2 ± 0.2 10.6 ± 0.2 10.2 ± 0.2 NS
Total Gn dose (IU) 4454.0 ± 286.5 5342.9 ± 404.9.5 4592.9 ± 415.5 NS
Total follicles developed 19.7 ± 0.9b 19.4 ± 1.1b 22.5 ± 1.1a 0.029
Follicles ≥14 mm day of hCG 10.9 ± 0.4b 10.6 ± 0.6b 12.2 ± 0.6a 0.049
E2 day of hCG (pg/mL) 2508.7 ± 84.1 2396.3 ± 194.2 2363.5 ± 107.8 NS
Endometrium thickness on day of hCG (mm) 10.2 ± 0.2 10.6 ± 0.2 10.7 ± 0.3 NS
Oocytes collected 13.7 ± 0.7 13.9 ± 1.1 15.4 ± 0.9 NS
Mature oocytes 10.9 ± 0.6 11.4 ± 0.8 12.0 ± 0.7 NS
Oocytes fertilized 8.4 ± 0.5 9.2 ± 0.7 9.3 ± 0.6 NS
Embryos transferred 2.6 ± 0.1 2.5 ± 0.1 2.8 ± 0.1 NS
CPR (%) 61/136 (44.9) 35/84 (41.7) 28/75 (37.3) NS
LBR (%), n=292* 54/136 (39.7) 30/81 (37.0) 24/75 (32.0) NS

Except otherwise stated results are means ± SE from two-way ANOVAs with Tukey post hoc analysis as appropriate. No interactions were detected between BMI and hCG. Different letters denote differences among groups (a vs. b, a vs.c, and b vs. c; P<0.05). BMI; Body mass index, u-hCG; Urinary derived human chorionic gonadotropin, Gn; Gonadotropin, E2; Estradiol, CPR; Clinical pregnancy rate, LBR; Live birth rate, NS; Nonsignificant, and *; 3 cycles were lost to follow up hence the outcome of pregnancy in these 3 cases was not known.